Several lines of evidence indicate that the HD mutation confers a CAG length-dependent ‘gain-of-function’ that likely produces its distinctive neuropathology through a modulatory effect on some structural or functional feature of huntingtin [6]–[9]. This evidence concerns the gene HTT and Huntington disease.